New Traditional Chinese Medicine Supplement Reduces Pain Faster than Conventional Pain Pills Alone: A Phase I/II Prospective,Double-Blinded Placebo-Controlled Randomized Trial

Abstract

Background

The opioid crisis demands novel solutions for postoperative pain control. Traditional Chinese medicine (TCM) has used herbs for the treatment of pain for thousands of years. We studied whether a synergistic multimodal TCM supplement could reduce the need for conventional pain pills for low risk surgical procedures.

Methods

In a Phase I/II, prospective, double-blind, placebo-controlled, randomized clinical trial (PRCT), 93 patients were randomized to either TCM supplement or placebo oral medication for low-risk outpatient surgical procedures. Study medications began 3 days preoperatively and continued for 5 days postoperatively. Conventional pain pill use was not restricted. Patients were monitored postoperatively for all forms of pain pill use (Pain Pill Scoring Sheet) and subjective pain ratings (Brief Pain Inventory Short Form). Primary outcomes included type and number of pain pills used and subjective pain ratings. Secondary outcomes included an assessment of mood, general activity, sleep, and enjoyment of life.

Results

TCM use well tolerated. Conventional pain pill use was similar between groups. Linear regression analysis revealed that TCM reduced postoperative pain 3 times faster than placebo (P < .0001) with a 4-fold greater magnitude of relief by postoperative day 5 (P = .008). TCM also significantly improved sleep habits (P = .049) during the postoperative period. TCM effect was independent of type of surgery or amount of preoperative pain.

Discussion

This PRCT is the first to show that a multimodal, synergistic TCM supplement is safe and can effectively reduce acute postoperative pain more rapidly, and to a lower level, than conventional pain pills alone.

Keywords

outpatient surgery hernia vasectomy herbal supplement opioids traditional Chinese medicine acute pain postoperative pain control

Get full access to this article

View all access options for this article.

References

Substance Abuse and Mental Health Services Administration . Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health: HHS Publication(No. PEP20-07-01-001, NSDUH Series H-55). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/. (Accessed December 2, 2022).

Compton

Boyle

Wargo

. Prescription opioid abuse: Problems and responses. Prev Med. 2015;80:5-9.

Centers for Disease Control and Prevention . U.S. opioid dispensing rate maps. Centers for Disease Control and Prevention. https://www.cdc.gov/drugoverdose/rxrate-maps/index.html. https://www.cdc.gov/drugoverdose/rxrate-maps/index.html. (Accessed December 21, 2022).

Centers for Disease Control and Prevention . Death rate maps and graphs. Centers for disease control and prevention. https://www.cdc.gov/drugoverdose/deaths/index.html#:∼:text=Opioids%20were%20involved%20in%2068%2C630,and%20without%20synthetic%20opioid%20involvement. (Accessed December 21, 2022).

Brubaker

Kendall

Reina

. Multimodal analgesia: A systematic review of local NSAIDs for non-ophthalmologic postoperative pain management. Int J Surg. 2016;32:158-166. DOI: 10.1016/j.ijsu.2016.07.003

. Can eastern wisdom resolve western epidemics? Traditional Chinese medicine therapies and the opioid crisis. J Integr Med. 2021;19(4):295-299.

Wang

Zhang

Wang

, et al. The antinociceptive properties of the corydalis yanhusuo extract. PLoS One. 2016;11(9):e0162875.

Chen